Highlights
NASDAQ: GBT       Global Blood Ther
Last Price Today's Change   Day's Range   Trading Volume
41.45   +1.40 (3.50%)  37.10 - 45.45  1,475,482

Overview

 
Avg Volume (4 weeks):897,821
4 Weeks Range:37.10 - 51.65
4 Weeks Price Volatility (%):
29.90%
52 Weeks Range:24.02 - 68.05
52 Weeks Price Volatility (%):
39.59%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.

  Be the first to like this.
 


 

4559  2967  379  647 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMD 17.085+0.745 
 EEM 44.645-0.585 
 T 32.175-0.975 
 GXP 31.990.00 
 WR 54.000.00 
 GE 13.175-0.125 
 JD 43.76+0.17 
 SPY 276.185-0.945 
 BAC 29.39+0.11 
 IQ 43.38+3.22 
Partners & Brokers